MYTESI 125 mg/1
Crofelemer · TABLET, COATED · Napo Pharmaceuticals, Inc.
No Recall History
Plain English
MYTESI is a tablet, coated containing crofelemer at 125 mg/1, taken oral. Manufactured by Napo Pharmaceuticals, Inc..
Key Facts
- Brand Name
- MYTESI
- Generic Name
- Crofelemer
- NDC Code (Product)
70564-802- Manufacturer
- Napo Pharmaceuticals, Inc.
- Strength
- 125 mg/1
- Dosage Form
- TABLET, COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA202292
- Drug Class
- Antidiarrheal [EPC]
- Marketing Start
- 08/01/2016
Recall History
No Recall HistoryFrequently Asked Questions
What is MYTESI used for?
MYTESI contains Crofelemer. It is a tablet, coated taken oral. Consult your doctor for specific uses.
Is MYTESI a controlled substance?
MYTESI is not classified as a controlled substance by the DEA.
What is the generic name for MYTESI?
The generic name for MYTESI is Crofelemer. There are no other listed brand versions of Crofelemer.
What is the NDC code for MYTESI 125 mg/1?
The NDC (National Drug Code) for MYTESI 125 mg/1 is 70564-802, listed by Napo Pharmaceuticals, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)